Provectus Pharmaceuticals, Inc. was granted patents in China and Europe for the use of PV-10 as an imaging agent for CT and MRI scans. PV-10, which is commonly known as Rose Bengal, was given the patent as an imaging agent for diagnosis of cancer. However, the use of PV-10 as an imaging agent is less important to Provectus than use of the drug as a treatment for cancer and dermatological conditions. Clinical trials for both indications are in progress. More details...

Stock Symbol: (OTCBB: PVCT)

The Chinese patent system has recently experienced tidal waves of change in its statutes and administrative rules. Innovative industries that expect to obtain patent protection in China will continue to be profoundly touched by these waves of change. This article was written by Charles C. Liu, PhD, JD, Partner, Director of US Practice, Unitalen Attorneys at Law and Jeanne J. Liu.  In this last of four installments, the authors discuss “Patent Misuse and Unfaithful Proceedings,” “Compulsory Licenses,” “Disclosure of Genetic Resources” and “Designation of Patent Firms to Handle Foreign-Related Matters.” More details...

The Chinese patent system has recently experienced tidal waves of change in its statutes and administrative rules. Innovative industries that expect to obtain patent protection in China will continue to be profoundly touched by these waves of change. This article was written by Charles C. Liu, PhD, JD, Partner, Director of US Practice, Unitalen Attorneys at Law and Jeanne J. Liu.  In this third of four installments, the authors discuss “Foreign Filing License and Patent Export Control,” “Administrative Enforcement” and “Administrative Control.” More details...

The Chinese patent system has recently experienced tidal waves of change in its statutes and administrative rules. Innovative industries that expect to obtain patent protection in China will continue to be profoundly touched by these waves of change. This article was written by Dr. Charles C. Liu, PhD, JD, Partner, Director of US Practice, Unitalen Attorneys at Law and Jeanne J. Liu.  In this second of four installments, the authors discuss "Design Patents," and "Division Applications." More details...

The Chinese patent system has recently experienced tidal waves of change in its statutes and administrative rules. Innovative industries that expect to obtain patent protection in China will continue to be profoundly touched by these waves of change. This article was written by Dr. Charles C. Liu, PhD, JD, Partner, Director of US Practice, Unitalen Attorneys at Law and Jeanne J. Liu.  It will appear in four installments, covering proposed changes to China's patent law.  This installment covers the issues of "Novelty and Inventiveness" and "Crossover between the Invention and Utility Models."  More details...